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Aim. Intersectin 1 (ITSN1) gene encodes an evolutionarily conserved adaptor protein that functions in
clathrin-mediated endocytosis, cell signalling, apoptosis and cytoskeleton rearrangements. Its expression
is characterized by multiple alternative splicing. Alternative promoter usage is an additional way to create
diversity and flexibility in the regulation of gene expression. The aim of this study was to identify possible
alternative promoters of ITSN1 gene. Methods. In silico prediction, 5′ RACE, RT-PCR and reporter gene
expression assay were used for identification and functional characterization of alternative promoter
region. Results. We detected an alternative promoter of human ITSN1 gene which is located in intron 5 and
generates 5′ truncated transcripts containing in-frame ATG codon with strong Kozak sequence and could
encode an N-terminally truncated isoforms lacking first EH domain. The region located 246–190 bp
upstream of exon 6 is required for alternative promoter activity. ITSN1 transcripts generated from an
alternative promoter were detected in human kidney, liver, lung and brain tissues. However, the level of
their expression was significantly lower than that of major ITSN1 isoforms. Conclusion. The results
obtained suggest that alternative promoter region located in intron 5 of ITSN1 gene functions as a weak
promoter. Further experiments are required to clarify the role of 5′ truncated ITSN1 transcripts.
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Introduction. Intersectin 1 (ITSN1) is a conserved
adaptor protein implicated in clathrin-mediated endo-
cytosis, apoptosis, signal transduction and cytoskele-
ton organization (for a review see [1]). Its expression is
characterized by multiple alternative splicing [2–4].
The major ITSN1 protein isoforms described in mam-
mals are ubiquitously expressed short form, ITSN1-S,
and the long form, ITSN1-L, that is mainly expressed
in neurons. The short form consists of two N-terminal
Eps15 homology domains (EH1 and EH2), a coiled-
coil region and five Src homology domains (SH3 A–
E). The long form contains C-terminal extension with a 
Dbl homology (DH), a pleckstrin homology (PH), and
a C2 domains [1]. Recently, we described 15 additional 
ITSN1 transcriptional isoforms generated by different
combinations of alternatively spliced exons [5].
Several lines of evidence suggested that a large
fraction of human genes possesses multiple promoters
which could be regulated in a different manner and
complements alternative splicing in generating diffe-
rent protein isoforms [6]. Here we report the identi-
fication of an alternative promoter of ITSN1 gene
which is located in intron 5 and generates 5′ truncated
ITSN1 transcripts.
Materials and methods. RNA isolation and RT-
PCR. Total RNA from human tissues was isolated as
described previously [5]. cDNA was synthesized from
1 to 5 µg of total RNA using oligo(dT) primer and
Expand Reverse Transcriptase («Roche», France). Five 
percent of the cDNA obtained was used as a template
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for PCR as described previously [5]. The following oli- 
gonucleotides were used for expression analysis of
transcripts generated from an alternative promoter:
exon 5, forward – 
543-ATCAGCTACCCTCTGCACTTCC-564; 
exon 9,  reverse –
1041-TGAGCCTGTGGTAAACTTGACTGC-1018;
AP210, forward –
35122238-GTTCTGTCTTCAGGTTGAGTC-35122258;
β-actin, forward – 
5′-GAAATCGTGCGTGACATTAAG-3′; 
β-actin, reverse –
5′-AAGCATTTGCGGTGGACGATGGAG-3′; 
GAPDH, forward –
5′-TGAAGGTCGGAGTCAACGGATTTGGT-3′; 
GAPDH, reverse –
5′-CATGTGGGCCATGAGGTCCACCAC-3′. 
For the detection of alternative splicing events in
the 5′ UTR the following oligonucleotides were used: 
exon 1, forward –
2-AGCAAGCTTGGGAGCGAAGGAGGT-25; 
exon 1à, forward –
 35061642-TTCCCAAATGCGGCATCTGTGT-35061663;  
exon 1b, reverse –
35088748-GGGGTGTGAAGTGATCAACTCA-35088769;
exon 6, reverse –
730-AGCTGCTGTGGGAACAGAAGAT-709.
Nucleotide positions for oligonucleotides are based 
on the ITSN1-L and ITSN1-S cDNAs and genomic se-
quence of chromosome 21 (GenBank accession num-
bers NM_001001132.1, NM_003024.2 and NC_
000021.8). 
5′ RACE was performed using human fetal brain
and lung total RNAs and the 5′/3′ RACE kit («Roche»)
according to the manufacturer’s instructions. The pri-
mers used for 5′ RACE were 5′-GGCCACATCAAATG
ACTGT-3′ and 5′-ATTTCTTGCCTTTGGGTGGTC-3′.
Cell culture and transfection. The cell lines HeLa
and HEK293 were grown at 37 oC in 5 % CO2 in Dul-
becco’s modified Eagle’s medium supplemented with
10 % fetal bovine serum, 50 U/ml penicillin and
100 µg/ml streptomycin. The cells were transfected
using JetPEI (Polyplus Transfection). Cells grown in
12-well plates at 60–70 % confluence were transfected
in duplicate with 3 µg reporter gene constructs and
300 ng of Renilla luciferase expression vector,
pRL-TK. Cells were collected 42 h after transfection.
Cell extracts were assayed for Firefly and Renilla
luciferase activities using the Dual Luciferase Reporter 
Assay System («Promega», USA) and VICTOR3 Mul-
tilabel Counter 1420 («PerkinElmer», USA). Relative
luciferase activities were determined as the ratio of
Firefly luciferase activity of each sample to Renilla lu-
ciferase activity. 
Plasmids. For Dual Luciferase Reporter Assay,
PCR products corresponding to the regions of intron 5
of ITSN1 gene were subcloned upstream the luciferase
gene in pGL3-basic expression vector («Promega»).
All PCR-generated DNA fragments were sequenced to
confirm fidelity.
Results and Discussion. Identification of alterna-
tive transcription start sites in the human ITSN1 gene.
To search the putative alternative promoters of ITSN1
gene we analyzed database of transcription start sites,
DBTSS, based on experimentally determined 5′ end
clones [7] and found two clones with putative trans-
cription start sites located in introns 5 and 12. Then we
performed 5′ RACEs on human fetal lung and brain
total RNAs with antisense primers within exons 6 and
13. Discrete bands were obtained only with primers
specific to exon 6. 5′ ends of RACE products were
located 343, 323 and 285 bp directly upstream of the
exon 6 (Fig. 1, A). 
To verify the obtained results and more precisely
map possible transcription start sites, RT-PCRs with
different sense primers located at positions 36, 210,
338, 415 and 526 bp upstream of exon 6 and antisense
primer within exon 9 were performed. The results
suggest that alternative transcription start sites are
located at positions between 285–415 bp upstream of
exon 6 (Fig. 1, B). The 5′ end of the longest 5′ RACE
product was designated as +1. Sequence analysis
revealed the alternative in-frame ATG codon located in 
exon 6 (at position +347 bp) that contains strong Kozak 
sequence (GGTATGG) and could be considered as
good candidate for the initiation of the translation. The
resulting ORF could encode an N-terminally truncated
version of ITSN1 that lacks first EH domain. 
Functional conformation of alternative promoter
region using reporter gene analysis. To determine
whether the putative alternative promoter region has
functional promoter activity, three fragments of the
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intron 5 spanning the region from –1157 to +153 bp
were cloned into the promoterless pGL3-basic vector
upstream of the firefly luciferase coding sequence (Fig. 
2, A). Alternative promoter activity was analyzed in
HeLa and HEK293 cells in comparison with control
promoter of the herpes simplex virus thymidine kinase
(pTK-Luc) and major ITSN1 promoter located up-
stream of exon 1 (–997 +86 bp). The results of the
luciferase assays showed that all three alternative
promoter constructs were able to drive reporter gene
expression in both cell lines. In HEK293 cells the
activity of alternative promoter constructs was higher
than in HeLa, however it was approximately 3,5-fold
lower than the activity of TK promoter and 1,8-fold
lower than that of the major ITSN1 promoter. In HeLa
cells alternative promoter activity was 10-fold lower
than the activity of the major promoter.
Mapping the regions of promoter activity. We ge-
nerated a series of deletion constructs in order to loca-
lize regulatory sequence elements and the minimal pro- 
moter region. Deletion of the region located between
+97 and –23 bp did not result in significant decrease of
luciferase activity (Fig. 2, B). When HEK293 cells
were transfected with pAP-283∆1, pAP-283∆2, pAP-
667∆8, pAP-667∆6 and pAP-1157∆7 constructs, the
promoter activity was slightly increased, thereby sug-
gesting the presence of a negative regulatory element
located between –675 and –23 bp. However, deletion
of the segment between +97 and +153 bp caused mar-
ked decreases of luciferase activity. These results imp-
ly that the +97 to +153 bp region is required for alter-
native ITSN1 promoter activity. 
Analysis of expression of ITSN1 transcripts gene-
rated from an alternative promoter. The mammalian
ITSN1 gene produces two major isoforms, ITSN1-S
and ITSN1-L [1]. To analyze the expression of ITSN1
transcripts produced from an alternative promoter,
nested RT-PCRs using a sense primer of intron 5 and
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Fig. 1. A – scheme of ITSN1 gene with domain organization of short isoform (exons of ITSN1 gene are numbered; partial sequence of intron 5 
and exon 6 of human ITSN1 gene is shown; sequence of exon 6 is underlined; positions of 5' ends of RACE products as well as transcription
start site predicted by DBTSS are indicated as arrows above the sequence; primers for 5' end mapping are indicated by arrows below the
sequence; consensus Kozak sequence is boxed; region required for promoter activity (∆4) is indicated by figure arrows above the sequence);
B – mapping of the 3' end of ITSN1 transcripts generated from an alternative promoter using RT-PCR with AP415 and AP526 primers
(control reactions without reverse transcriptase (–RT) are shown); C – analysis of expression of ITSN1 transcripts produced from the major
(I) and alternative (II) promoters and control GAPDH gene (III) in fetal and adult human tissues; wk – week of fetus 
antisense primers specific for the short and long ITSN1
isoforms were performed. PCR products were detected
only with primers specific to ITSN1-S isoform. Sub-
sequent cloning and sequencing of these products
showed that they represent two different splice variants 
of ITSN1-S (Fig. 3). A first transcript was amplified
from fetal kidney. It lacks exons 25 and 26 that encode
the SH3C domain involved in interaction with proline-
rich motifs of dynamin 1, synaptojanin 1, SOS1,
WNK-kinase and other proteins [8–10]. The second
transcript was detected in fetal lung tissue and was
characterized by unusual for ITSN1 combination of
alternatively spliced exons. It contains elongated exon
12 due to the use of an alternative 3′ splicing site
located 22 nt upstream of the 5′ end of exon 12 and
lacks exons 25, 26 and 27. This combination of alter-
native splicing events shifts the open reading frame and 
introduces stop codons. 
To examine further the expression of the ITSN1
transcripts, RT-PCR was performed on total RNAs
from different tissues using primers specific for the
amplification of ITSN1 mRNAs originating from the
major and alternative promoters. The expression of
ITSN1 transcripts generated from an alternative
promoter was significantly lower than that of major
ITSN1 isoforms. RT-PCR products of transcripts pro-
duced from an alternative promoter were observed in
fetal kidney, liver, lung and brain, as well as in adult
kidney and ovary (Fig. 1, C). However, a second step of 
PCR amplification with nested primers revealed the
presence of these transcripts in all tissues tested indica-
ting the low level of their expression (data not shown).
RT-PCR analysis and results of luciferase assays sug-
gest that identified alternative promoter region func-
tions as a weak promoter. We could not use Western
blot analysis to study the expression of ITSN1 proteins
encoded by transcripts from an alternative promoter
since the molecular weight of these proteins coincides
with that of alternatively spliced ITSN1-22a isoform.
Alternative splicing affecting the 5′ UTR of ITSN1
mRNA. 5′ untranslated region (5′ UTR) of human
ITSN1 mRNA produced from the major promoter con-
118
KROPYVKO S. V. ET AL.
Fig. 2. A – activity of ITSN1 alternative promoter in HeLa and HEK293 cells (cells were transfected with sequentially deleted reported
constructs of the –1157 +153 bp sequence; transient transfection and luciferase assays were performed in triplicate; the data were
normalized to renilla luciferase activity and are shown as relative activities compared to that for pTK-Luc; the mean values and standard
deviations were calculated from three experiments); B – mapping of ITSN1 alternative promoter region (deletion constructs of ITSN1
alternative promoter region used for luciferase assay in cell line HEK293 are indicated) 
sists of two exons and could start from seven different
transcriptional start sites according to CAGE-tags da-
tabase. While analyzing GenBank Database we found
two ESTs that had high homology with human ITSN1
gene and carried two insertions of 62 and 187 bp lo-
cated between exons 1 and 2. The insertions are gene-
rated due to addition of two exons of 62 and 125 bp that
were designated as exons 1a and 1b (Fig. 4, A). The
combination of exons 1a and 1b resulted in an insertion
of 187 bp. Start-codon of ITSN1 is located in exon 2
and addition of two supplementary exons expands the
total length of 5′ UTR of ITSN1 mRNA and potentially
could affect translation efficiency, mRNA transport
and stability.
To explore tissue specificity of ITSN1 transcripts
with two supplementary exons, we performed RT-PCR 
and found that these isoforms are widely expressed in
the majority of tissues without any significant tissue
specificity (Fig. 4). Our further experiments showed
that exons 1a and 1b are predominantly spliced in a
mutually exclusive fashion. Using primers within
exons 1a and 6 we obtained PCR product of 700 bp that
corresponds to the isoform containing exon 1a, but
failed to amplify the 825-bp PCR product containing
both exons 1a and 1b (Fig. 4, B). To confirm these
findings, we performed RT-PCR using sense primer
within exon 1 and antisense primer specific to exon 1b.
The results indicated the presence of the products of
269 bp representing the transcript with exon 1b and
absence of the 331-bp product corresponding to the
isoforms containing exons 1a and 1b (Fig. 4, C). 
Thus, we identified alternative promoter of ITSN1
gene that generates novel transcript variants and the-
refore diversifies functions of endocytic adapter pro-
tein ITSN1. The data concerning alternative splicing
events within 5′ UTR could be also important for fur-
ther understanding of ITSN1 regulation at posttrans-
criptional level.
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Fig. 3. Schematic representation of the ITSN1 transcripts produced from an alternative promoter (I, II) and domain structure of the two main
isoforms, short (ITSN1-S) and long (ITSN1-L). ITSN1 exons are shown as black and white boxes and numbered above. Stop codons are
marked by asterisks 
Fig. 4. A – schematic representation of splicing events affected 5'
UTR of human ITSN1 mRNA; B – analysis of expression of  ITSN1
isoforms containing exon 1a using primers specific for exons 1a and 
6  (BI); C – analysis of expression of  ITSN1 isoforms containing
exon 1b using primers specific for exons 1 and 1b (CI); B, C (II)  –
analysis of expression of control genes GAPDH and β-actin
C. Â. Êðî ïèâ êî, Ë. Î. Öèáà, ². ß. Ñêðèïê³íà, À. Â. Ðèí äè÷
²äåí òèô³êàö³ÿ òà ôóíêö³îíàëü íèé àíàë³ç àëü òåð íà òèâ íî ãî 
ïðî ìî òîðó ãåíà ³íòåð ñåê òè íó 1 ëþ äè íè
Ðå çþ ìå
Ìåòà. Ãåí ³íòåð ñåê òè íó 1 (ITSN1) êîäóº åâî ëþö³éíî êîí ñåð âà -
òèâíèé àäàï òåð íèé á³ëîê, ïðè ÷åò íèé äî êëàò ðèí-îïî ñå ðåä êî -
âàíîãî åí äî öè òîçó, âíóòð³øíüîêë³òèííî¿ ïå ðå äà÷³ ñèã íà ëó,
àïîï òîçó òà ðå îð ãàí³çàö³¿ öè òîñ êå ëå òó. Éîãî åêñïðåñ³ÿ ïî â‘ÿ -
çàíà ç áà ãàòü ìÿ ïîä³ÿìè àëü òåð íà òèâ íî ãî ñïëàé ñèí ãó. Äî äàò -
êîâèì ñïî ñî áîì äî ñÿã íåí íÿ ð³çíî ìàí³òòÿ ³ òîí êî¿ ðå ãó ëÿö³¿
åêñïðåñ³¿ ãåí³â º ïîøóê àëü òåð íà òèâ íèõ ïðî ìî òîð³â. Ìåòà ðî-
áîòè ïî ëÿ ãà ëà ó âè ÿâ ëåíí³ ìîæ ëè âèõ àëü òåð íà òèâ íèõ ïðî ìî -
òîð³â ãåíà ITSN1. Ìå òî äè. Çàñ òî ñî âà à íî êîì ï’þ òåð íå ïå ðåä-
áà ÷åí íÿ, 5' RACE, RT-ÐCR ³ òåñò, îñíî âà íèé íà àíàë³ç³ åêñïðå-
ñ³¿ ðå ïîð òåð íî ãî ãåíà. Ðå çóëü òà òè. Âè ÿâ ëå íî àëü òåð íà òèâ íèé 
ïðî ìî òîð ãåíà ITSN1 ëþ äè íè, ëî êàë³çî âà íèé ó 5-ìó ³íòðîí³,
âíàñë³äîê âèêîðèñòàííÿ ÿêîãî óòâî ðþ þòü ñÿ òðàíñ êðèï òè ç
â³äêðè òîþ ðàì êîþ ç÷è òó âàííÿ òà êîí ñåí ñóñ íîþ ïîñë³äîâ-
í³ñòþ Êî çàê, çäàòí³ êî äó âà òè ITSN1-³çî ôîð ìè áåç ïåð øî ãî
EH-äî ìå íó. Âèç íà ÷å íî, ùî ä³ëÿí êà, ðîç òà øîâàíà çà 246–190 ï.
í. äî ïî ÷àò êó 6-ãî åê çî íà, íå îáõ³äíà äëÿ ôóíêö³îíó âàí íÿ àëü -
òåð íà òèâ íî ãî ïðî ìî òî ðó. Òðà íñêðèï òè ITSN1, ùî óòâî ðþ -
þòü ñÿ â ðå çóëü òàò³ âè êî ðèñ òàí íÿ àëüòåð íà òèâ íî ãî ïðî ìî-
òîðó, çíàé äå íî â òêà íè íàõ íè ðîê, ïå÷³íêè, ëå ãåíü ³ ìîç êó ëþ äè -
íè, ïðî òå ð³âåíü ¿õíüî¿ åêñïðåñ³¿ çíà÷ íî íè æ÷èé ïîð³âíÿ íî ç
îñíîâ íè ìè ³çî ôîð ìà ìè ITSN1. Âèñ íîâêè. Îòðè ìàí³ äàí³ ñâ³ä-
÷àòü ïðî òå, ùî àëü òåð íà òèâ íèé ïðî ìî òîð, ëî êàë³çî âà íèé ó
5-ìó ³íòðîí³ ãåíà ITSN1 ëþ äè íè, ôóíêö³îíóº ÿê ñëàá êèé ïðî ìî -
òîð. Ïî äàëüø³ äîñë³äæåí íÿ íå îáõ³äí³ äëÿ ç’ÿñó âàí íÿ ôóíêö³¿
òðàíñ êðèïò³â ITSN1 ç àëü òåð íà òèâ íèì 5'-ê³íöåì.
Êëþ ÷îâ³ ñëî âà: ³íòåð ñåê òèí 1, àëü òåð íà òèâ íèé ïðî ìî òîð,
àëü òåð íà òèâ íèé ñïëàé ñèíã, àäàï òåðí³ á³ëêè, 5’ UTR.
Ñ. Â. Êðî ïèâ êî, Ë. A. Öèáà, È. ß. Ñêðèï êè íà, À. Â. Ðûí äè÷
Èäåí òè ôè êà öèÿ è ôóíê öè î íàëü íûé àíà ëèç àëü òåð íà òèâ íî ãî
ïðî ìî òî ðà ãåíà èí òåð ñåê òè íà 1 ÷å ëî âå êà
Ðå çþ ìå
Öåëü. Ãåí èí òåð ñåê òè íà 1 (ITSN1) êî äè ðó åò ýâî ëþ öè îí íî êîí -
ñåð âà òèâ íûé àäàï òåð íûé áå ëîê, ó÷àñ òâó þ ùèé â êëàò ðèí-îïî-
ñðå äî âàí íîì ýí äî öè òî çå, âíóò ðèê ëå òî÷ íîé ïå ðå äà ÷å ñèã íà ëà,
àïîï òî çå è ðå îð ãà íè çà öèè öè òîñ êå ëå òà. Åãî ýêñ ïðåñ ñèÿ õà ðàê -
òå ðè çó åò ñÿ ìíî ãî ÷èñ ëåí íû ìè ñî áû òè ÿ ìè àëü òåð íà òèâ íî ãî
ñïëàé ñèí ãà. Äî ïîë íè òåëü íûì ñïî ñî áîì äîñ òè æå íèÿ ðàç íî îá -
ðàçèÿ è òîí êîé ðå ãó ëÿ öèè ýêñ ïðåñ ñèè ãå íîâ ÿâ ëÿ åò ñÿ èñ ïîëü çî -
âà íèå àëü òåð íà òèâ íûõ ïðî ìî òî ðîâ. Öåëü äàí íîé ðà áî òû ñî-
ñòî ÿ ëà â îá íà ðó æå íèè âîç ìîæ íûõ àëü òåð íà òèâ íûõ ïðî ìî òî -
ðîâ ãåíà ITSN1. Ìå òî äû. Ïðè ìå íåíû êîì ïüþ òåð íîå ïðåä ñêà -
çà íèå, 5' RACE, RT-PCR è òåñò, îñíî âàí íûé íà àíà ëè çå ýêñ-
ïðå ññèè ðå ïîð òåð íî ãî ãåíà. Ðå çóëü òà òû. Íàìè âûÿâëåí àëü -
òåð íà òèâ íûé ïðî ìî òîð ãåíà ITSN1 ÷å ëî âå êà, ëî êà ëè çî âàí íûé
â 5-ì èí òðî íå, â ðå çóëü òà òå èñ ïîëü çî âà íèÿ êî òî ðî ãî îá ðà çó -
þò ñÿ òðàíñ êðèï òû ñ îò êðû òîé ðàì êîé ñ÷è òû âà íèÿ è êîí ñåí -
ñóñ íîé ïî ñëå äî âà òåëü íîñ òüþ Êî çàê, ñïîñîáíûå êî äè ðî âàòü
èçî ôîð ìû ITSN1 áåç ïåð âî ãî ÅÍ-äî ìåíà. Ïî êà çà íî, ÷òî ó÷àñ -
òîê, íà õî äÿ ùèé ñÿ çà 246–190 ï. í. äî íà ÷à ëà 6-ãî ýê çî íà, íå îá -
õî äèì äëÿ ôóíê öè î íè ðî âà íèÿ àëü òåð íà òèâ íî ãî ïðî ìî òî ðà.
Òðà íñêðèï òû ITSN1, ïî ëó ÷åí íûå ñ àëü òåð íà òèâ íî ãî ïðî ìî òî -
ðà, îá íà ðó æå íû â òêà íÿõ ïî ÷åê, ïå ÷å íè, ëåãêèõ è ìîç ãà ÷å ëî âå -
êà, íî óðî âåíü èõ ýêñ ïðåñ ñèè çíà ÷è òåëü íî íèæå ïî ñðàâ íå íèþ ñ
îñíîâ íû ìè èçîôîð ìà ìè ITSN1. Âû âî äû. Ïî ëó ÷åí íûå ðå çóëü òà -
òû ñâè äå ò åëüñòâó þò î òîì, ÷òî àëü òåð íà òèâ íûé ïðî ìî òîð,
ëî êà ëè çî âàí íûé â 5-ì èí òðî íå ãåíà ITSN1, ôóíê öè î íè ðó åò êàê
ñëà áûé ïðî ìî òîð. Äàëü íåé øèå èñ ñëå äî âà íèÿ íå îá õî äè ìû äëÿ
âû ÿñ íå íèÿ ôóíê öèè òðàíñ êðèï òîâ ITSN1 ñ àëü òåð íà òèâ íûì
5'-êîí öîì. 
Êëþ ÷å âûå ñëî âà: èí òåð ñåê òèí 1, àëü òåð íà òèâ íûé ïðî ìî -
òîð, àëü òåð íà òèâ íûé ñïëàé ñèíã, àäàï òåð íûå áåë êè, 5' UTR.
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